Eli Lilly and Company
LLYNYSE
USReal-Time Price
USReal-Time Price$1,240.34USD
-16.69 (-1.33%)Today
$1,242.11+1.77 (+0.14%)After Hours7:59 PM ET
BTI Score
Near Future
67
Long Term
70
BTI Fair Market Cap
$471.53B
+150.95% vs fair
Buy
Eli Lilly and Company (LLY) Valuation
Is Eli Lilly and Company (LLY) overvalued or undervalued? BTI's fair-value estimate, DCF model and valuation multiples show the premium or discount to intrinsic worth.
Valuation Snapshot
P/E (TTM)
Trailing Price-to-Earnings
41.50
Forward P/E
Next 12 months estimate
—
PEG Ratio
P/E to Growth ratio
—
Price / Sales
Market cap vs. revenue
—
Price / Book
Market cap vs. book value
—
EV / EBITDA
Enterprise value multiple
—
Earnings Yield
Inverse of P/E
2.41%
Revenue Growth
Year-over-year
—
Valuation Risk
Eli Lilly and Company's valuation multiples are within a moderate range, suggesting the market is not pricing in excessive optimism. Investors should monitor growth execution relative to valuation.
Run Full Valuation Model
DCF, multiples, scenario analysis and AI fair value for LLY